FY26 2-28 FEB -- mat (90F) medications only - mckesson contract acct #077960 and 677508-- 90F/ 1060ADB funding for mat medication purchase (controlled & non-controlled medications)
Ended Awarded Last action
- Contract number
- 15B10926F00000060
- Awardee
-
Mckesson Corporation UEI S1RUKWWRYFL6
- Awarding agency
-
Federal Medical Center Lexington
Correctional Facilities, Department of Justice
- Obligated
- $19,993
Award facts
- Contract value 100% obligated
- $19,992.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Irving, TX 75039, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$971 | |
| Original award | $20,964 |
About this award
The Federal Bureau of Prisons, through the Federal Medical Center Lexington, awarded a delivery order to McKesson Corporation on February 1, 2026, for the procurement of medications to support the agency's Medication-Assisted Treatment (MAT) program. The delivery order, valued at $19,992.83 with a ceiling request of $20,963.69, covers both controlled and non-controlled medications sourced through McKesson's established pharmaceutical distribution accounts. The award represents a firm fixed-price delivery order with an ultimate completion date of March 12, 2026, and no small business set-aside designation. McKesson will perform the work from its headquarters in Irving, Texas, leveraging its substantial pharmaceutical distribution infrastructure that serves federal correctional facilities nationwide.
This award exemplifies McKesson's established role as a critical pharmaceutical supplier to the Bureau of Prisons system, where the company maintains an extensive portfolio of delivery orders and purchase orders supporting medication procurement across federal correctional institutions. McKesson's federal contract engagement with the Department of Justice demonstrates the company's longstanding partnership with correctional healthcare operations, with individual task orders ranging significantly in value. The Medication-Assisted Treatment program represents a key component of federal correctional healthcare, providing evidence-based pharmaceutical interventions to support inmate health and rehabilitation objectives within the correctional system.
Quick answers
Who was awarded contract 15B10926F00000060?
15B10926F00000060 was awarded to Mckesson Corporation by Federal Medical Center Lexington (Correctional Facilities) on February 1, 2026.
How much is contract 15B10926F00000060 worth?
The government has obligated $19,993 on 15B10926F00000060.
Is contract 15B10926F00000060 an order under another contract?
Yes. 15B10926F00000060 is a delivery order under 36W79720D0001, an indefinite delivery contract.
Was contract 15B10926F00000060 competed?
The extent of competition for 15B10926F00000060 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award